QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 期刊论文 AUTOPHAGY, 2021, 卷号: 17 作者:  Klionsky, Daniel J.;  Abdel-Aziz, Amal Kamal;  Abdelfatah, Sara;  Abdellatif, Mahmoud;  Abdoli, Asghar 收藏  |  浏览/下载：265/0  |  提交时间：2021/05/31 Autophagosome  cancer  flux  LC3  lysosome  macroautophagy  neurodegeneration  phagophore  stress  vacuole   A Self-test Prediction Model to Determine the Probability Risk of Non-alcoholic Fatty Liver Disease 期刊论文 BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2020, 卷号: 33, 期号: 11, 页码: 857-861 作者:  Li Qiang;  Shen Qun Lun;  Xu Chao Nan;  Li Ming Liang;  Ma Zhi Min 收藏  |  浏览/下载：9/0  |  提交时间：2021/04/26 The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104) 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 3 作者:  Xu, Song-Tao;  Xi, Jun-Jie;  Zhong, Wen-Zhao;  Mao, Wei-Min;  Wu, Lin 收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05 NSCLC  EGFR  tyrosine kinase inhibitor  gefitinib  adjuvant chemotherapy   Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study 期刊论文 LANCET ONCOLOGY, 2018, 卷号: 19, 期号: 1 作者:  Zhong, Wen-Zhao;  Wang, Qun;  Mao, Wei-Min;  Xu, Song-Tao;  Wu, Lin 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study 期刊论文 The Lancet Oncology, 2018, 卷号: 19, 期号: 1, 页码: 139-148 作者:  Zhong, Wen-Zhao;  Wang, Qun;  Mao, Wei-Min;  Xu, Song-Tao;  Wu, Lin 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/03 A NON-INTERVENTIONAL STUDY ON EGFR MUTATION STATUS AND CLINICAL OUTCOMES OF CHINESE PATIENTS WITH COMPLETELY RESECTED LUNG ADENOCARCINOMA (ICAN STUDY) 会议论文 作者:  Wu, Yi-Long;  Wang, Jun;  Chu, Xiang-Yang;  Liu, Zhi-Dong;  Shen, Yi 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 adjuvant therapy  DFS  Chinese lung adenocarcinoma  EGFR mutation   A prospective comparison study on EGFR mutations by direct sequencing and ARMS in completely resected Chinese non-small cell lung cancer with adenocarcinoma histology (ICAN) 会议论文 作者:  Zhang, Xuchao;  Wu, Yi Long;  Wang, Jun;  Chu, Xiang-Yang;  Liu, Zhi-Dong 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 A NON-INTERVENTIONAL STUDY ON EGFR MUTATION STATUS AND CLINICAL OUTCOMES OF CHINESE PATIENTS WITH COMPLETELY RESECTED LUNG ADENOCARCINOMA (ICAN STUDY) 期刊论文 2013, 卷号: 8, 页码: S1114-S1115 作者:  Wu, Yi-Long;  Wang, Jun;  Chu, Xiang-Yang;  Liu, Zhi-Dong;  Shen, Yi 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/13 adjuvant therapy  DFS  Chinese lung adenocarcinoma  EGFR mutation